Crispr Therapeutics
Price & Volume
Stats
See more52W Range | $30.04-$71.13 |
Market Cap | $5.2B |
Shares Short | 23M |
Financials
See moreRevenue (12 Mos) | $38M |
Revenue Growth (YoY) | 72.5% |
Gross Profit (12 Mos) | -$382.4M |
Diluted EPS | -$5.40 |
News
See moreYahoo Finance • 20 hours ago
Which Gene Therapy Technology Wins? New Data from Spherix Global Insights Reveals Emerging Hematologist Preferences in Beta Thalassemia Care
Yahoo Finance • 3 days ago
Cathie Wood's ARK makes major moves in Trade Desk and Block stock
Yahoo Finance • 4 days ago
Benjamin Graham Detailed Fundamental Analysis - CRSP
Yahoo Finance • 11 days ago
Cathie Wood's ARK ETF adjusts portfolio with AMD and NVDA stock buys
About
CEO | Dr. Samarth Kulkarni Ph.D. |
Address | Baarerstrasse 14, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 393 |
